164 related articles for article (PubMed ID: 37749155)
1. The Warburg effect alters amino acid homeostasis in human retinal endothelial cells: implication for proliferative diabetic retinopathy.
Gregory A; Yumnamcha T; Shawky M; Eltanani S; Naghdi A; Ross BX; Lin X; Ibrahim AS
Sci Rep; 2023 Sep; 13(1):15973. PubMed ID: 37749155
[TBL] [Abstract][Full Text] [Related]
2. The Suppression of Kallistatin on High-Glucose-Induced Proliferation of Retinal Endothelial Cells in Diabetic Retinopathy.
Xing Q; Zhang G; Kang L; Wu J; Chen H; Liu G; Zhu R; Guan H; Lu P
Ophthalmic Res; 2017; 57(3):141-149. PubMed ID: 27537690
[TBL] [Abstract][Full Text] [Related]
3. Altered oxylipin levels in human vitreous indicate imbalance in pro-/anti-inflammatory homeostasis in proliferative diabetic retinopathy.
Zhao T; Wang Y; Guo X; Li H; Jiang W; Xiao Y; Deng B; Sun Y
Exp Eye Res; 2022 Jan; 214():108799. PubMed ID: 34687725
[TBL] [Abstract][Full Text] [Related]
4. MiR-181 Enhances Proliferative and Migratory Potentials of Retinal Endothelial Cells in Diabetic Retinopathy by Targeting KLF6.
Cao J; Zhao C; Gong L; Cheng X; Yang J; Zhu M; Lv X
Curr Eye Res; 2022 Jun; 47(6):882-888. PubMed ID: 35179443
[TBL] [Abstract][Full Text] [Related]
5. Aberrant lncRNA expression in patients with proliferative diabetic retinopathy: preliminary results from a single-center observational study.
Zeng L; Zhou M; Wang X; Long X; Ye M; Yuan Y; Tan W
BMC Ophthalmol; 2023 Mar; 23(1):94. PubMed ID: 36899334
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
[TBL] [Abstract][Full Text] [Related]
7. Free amino acids hydroxyproline, lysine, and glycine promote differentiation of retinal pericytes to adipocytes: A protective role against proliferative diabetic retinopathy.
Vidhya S; Ramya R; Coral K; Sulochana KN; Bharathidevi SR
Exp Eye Res; 2018 Aug; 173():179-187. PubMed ID: 29752946
[TBL] [Abstract][Full Text] [Related]
8. microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy.
Friedrich J; Steel DHW; Schlingemann RO; Koss MJ; Hammes HP; Krenning G; Klaassen I
Transl Vis Sci Technol; 2020 May; 9(6):16. PubMed ID: 32821513
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
[TBL] [Abstract][Full Text] [Related]
10. Vitreous metabolomics profiling of proliferative diabetic retinopathy.
Tomita Y; Cagnone G; Fu Z; Cakir B; Kotoda Y; Asakage M; Wakabayashi Y; Hellström A; Joyal JS; Talukdar S; Smith LEH; Usui Y
Diabetologia; 2021 Jan; 64(1):70-82. PubMed ID: 33099660
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
12. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
[TBL] [Abstract][Full Text] [Related]
13. Elevated protein carbonyl and HIF-1α levels in eyes with proliferative diabetic retinopathy.
Loukovaara S; Koivunen P; Inglés M; Escobar J; Vento M; Andersson S
Acta Ophthalmol; 2014 Jun; 92(4):323-7. PubMed ID: 23718695
[TBL] [Abstract][Full Text] [Related]
14. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown.
Pfeiffer A; Spranger J; Meyer-Schwickerath R; Schatz H
Diabetes; 1997 Sep; 46 Suppl 2():S26-30. PubMed ID: 9285495
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Investigation on Complement Pathway Activation in Diabetic Retinopathy.
Shahulhameed S; Vishwakarma S; Chhablani J; Tyagi M; Pappuru RR; Jakati S; Chakrabarti S; Kaur I
Front Immunol; 2020; 11():154. PubMed ID: 32117292
[TBL] [Abstract][Full Text] [Related]
16. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
17. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Wang Y; Gao S; Zhu Y; Shen X
Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
[TBL] [Abstract][Full Text] [Related]
18. [New exploration of treatment target for proliferative diabetic retinopathy based on iTRAQ LC-MS/MS Proteomics].
Wen DJ; Ren XJ; Dong LJ; He Y; Li XR
Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):769-776. PubMed ID: 31607066
[No Abstract] [Full Text] [Related]
19. Increased levels of cytokines in the aqueous humor correlate with the severity of diabetic retinopathy.
Song S; Yu X; Zhang P; Dai H
J Diabetes Complications; 2020 Sep; 34(9):107641. PubMed ID: 32605862
[TBL] [Abstract][Full Text] [Related]
20. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK
Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
